| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.33 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.74 | 0.03 |